Cargando…
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders
Our pathophysiological concept of the most common central nervous system demyelinating disease, multiple sclerosis, strikingly evolved by recent discoveries suggesting that B lymphocytes substantially contribute in its initiation and chronic propagation. In this regard, activated B cells are nowaday...
Autores principales: | Häusser-Kinzel, Silke, Weber, Martin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375838/ https://www.ncbi.nlm.nih.gov/pubmed/30800132 http://dx.doi.org/10.3389/fimmu.2019.00201 |
Ejemplares similares
-
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020) -
The Emerging Role of Microglia in Neuromyelitis Optica
por: Chen, Tingjun, et al.
Publicado: (2021) -
Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Ostendorf, Lennard, et al.
Publicado: (2019) -
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders
por: Traub, Jan, et al.
Publicado: (2021) -
The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023)